|
NEWS, EVENTS, and DEADLINES
October 28, 2026
| |
NJ ACTS, Rutgers, Princeton and NJIT Events | | | | Find out what impact your research or innovation could have in solving real-world problems by attending the Novus I-Corps program, a half-day introduction to I-Corps. | | NCATS, NIH, and Federal News and Events | | |
NIH has launched the $6 million Real-World Evidence Innovation Challenge, a national prize competition led by the National Center for Advancing Translational Sciences. The Challenge moves beyond model development alone to test whether analytic approaches remain reliable when applied across different health systems.
Participants must register by February 2, 2027. A technical assistance webinar will be held on February 16, 2027, and complete Phase 1 submissions are due by March 26, 2027, at 5:00 p.m. Eastern Time.
| | |
Policy for the use of Super Intelligence
The Federal Government is transitioning from the use of "Artificial Intelligence" and "AI" to "Super Intelligence" and "SI" pursuant to Section 2 of Executive Order (EO) 14434. The EO directs federal agencies to use "Super Intelligence" and "SI" in official documents and communications, including public communications, websites, and reports. Read More
| |
Zoom: October 28, November 4, November 11 (6 – 8 pm)
In person: “Policy in Action” Lecture Dates: November 20, November 21 (10 am – 4 pm) Alumni Multipurpose Room
This course will introduce participants to the disciplines of science policy and advocacy through the lens of U.S. federal science agencies. The Introductory Lectures will provide participants with a brief overview of the structure of the United States Government, its legislative and regulatory processes, and how government agencies determine funding levels and oversee federally supported research activities. Check out the syllabus and register!
| | |
Rutgers University Genetics Coordinating Center: How we run online genetics studies
Tara Matise, PhD
The Rutgers University Genetics Coordinating Study is conducting research studies on the genetics of breast cancer, blood cancer, kidney diseases, and pulmonary hypertension.
November 2
12 - 1 pm
Register
| | | |
Epic Cosmos Teleport – A New Paradigm for
Multi-Institutional Research Study Site and Patient Recruitment
November 18
12 - 1 pm
| | |
NJ ACTS Publication Highlights
Associations between e-cigarette marketing exposure and vaping nicotine and cannabis among U.S. adults, 2021. Chen-Sankey J, La Capria K, Glasser A, Padon AA, Moran MB, Wagoner KG, Jackson KM, Berg CJ. Addict Behav. 2024 Oct;157:108090. PMID: 38352380 PMCID: PMC10863020 DOI: 10.1101/2024.02.03.24302079
Associations between mycoestrogen exposure and sex steroid hormone concentrations in maternal serum and cord blood in the UPSIDE pregnancy cohort. Kinkade CW, Aleksunes LM, Brinker A, Buckley B, Brunner J, Wang C, Miller RK, O’Connor TG, Rivera-Núñez Z, Barrett ES. Int J Hyg Environ Health. 2024 Jul;260:114405. PMID: 38878407 PMCID: PMC11441442 DOI: 10.1016/j.ijheh.2024.114405
| |
NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| | NJ ACTS Resources, Services, Training Programs and Working Groups | | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)
| | | | |